SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

MetLife, Inc. – ‘10-K’ for 12/31/23 – ‘EX-10.24 9’

On:  Thursday, 2/15/24, at 6:42pm ET   ·   As of:  2/16/24   ·   For:  12/31/23   ·   Accession #:  1099219-24-35   ·   File #:  1-15787

Previous ‘10-K’:  ‘10-K’ on 2/23/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   47 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/16/24  MetLife, Inc.                     10-K       12/31/23  265:78M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML  15.13M 
 2: EX-4.18     Instrument Defining the Rights of Security Holders  HTML    295K 
 3: EX-10.10    Material Contract                                   HTML     78K 
 4: EX-10.21 16  Material Contract                                  HTML     71K 
 5: EX-10.24 9  Material Contract                                   HTML     70K 
 6: EX-10.27 1  Material Contract                                   HTML    150K 
 7: EX-21.1     Subsidiaries List                                   HTML    227K 
 8: EX-23.1     Consent of Expert or Counsel                        HTML     69K 
13: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     90K 
                Awarded Compensation                                             
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     73K 
10: EX-31.2     Certification -- §302 - SOA'02                      HTML     73K 
11: EX-32.1     Certification -- §906 - SOA'02                      HTML     70K 
12: EX-32.2     Certification -- §906 - SOA'02                      HTML     70K 
19: R1          Document and Entity Information                     HTML    153K 
20: R2          Audit Information                                   HTML     75K 
21: R3          Consolidated Balance Sheets                         HTML    222K 
22: R4          Consolidated Balance Sheets (Parenthetical)         HTML    108K 
23: R5          Consolidated Statements of Operations               HTML    182K 
24: R6          Consolidated Statements Of Comprehensive Income     HTML    131K 
25: R7          Consolidated Statements of Equity                   HTML    139K 
26: R8          Consolidated Statements of Cash Flows               HTML    246K 
27: R9          Statement of Cash Flows (Statement)                 HTML     71K 
                (Parenthetical)                                                  
28: R10         Business, Basis of Presentation and Summary of      HTML    655K 
                Significant Accounting Policies                                  
29: R11         Segment Information                                 HTML    457K 
30: R12         Dispositions - Dispositions                         HTML     77K 
31: R13         Future Policy Benefits                              HTML   1.25M 
32: R14         Policyholder Account Balances                       HTML    748K 
33: R15         Market Risk Benefits                                HTML    748K 
34: R16         Separate Account                                    HTML    346K 
35: R17         Deferred Policy Acquisition Costs, Value of         HTML    339K 
                Business Acquired and Other Policy-Related                       
                Intangibles                                                      
36: R18         Reinsurance                                         HTML    185K 
37: R19         Closed Block                                        HTML    141K 
38: R20         Investments                                         HTML    812K 
39: R21         Derivatives                                         HTML    649K 
40: R22         Fair Value                                          HTML    691K 
41: R23         Leases Leases                                       HTML    103K 
42: R24         Goodwill                                            HTML    153K 
43: R25         Long-term and Short-term Debt                       HTML    151K 
44: R26         Collateral Financing Arrangements                   HTML     84K 
45: R27         Junior Subordinated Debt Securities                 HTML    108K 
46: R28         Equity                                              HTML    463K 
47: R29         Other Revenues and Other Expenses                   HTML    113K 
48: R30         Employee Benefit Plans                              HTML    471K 
49: R31         Income Tax                                          HTML    176K 
50: R32         Earnings Per Common Share                           HTML     95K 
51: R33         Contingencies, Commitments and Guarantees           HTML    100K 
52: R34         Quarterly Results of Operations (Unaudited)         HTML    141K 
53: R35         Consolidated Summary of Investments - Other Than    HTML    111K 
                Investments in Related Parties                                   
54: R36         Condensed Financial Information (Parent Company)    HTML    256K 
55: R37         Consolidated Supplementary Insurance Information    HTML    222K 
56: R38         Consolidated Reinsurance                            HTML    125K 
57: R39         Pay vs Performance Disclosure                       HTML     82K 
58: R40         Insider Trading Arrangements                        HTML     93K 
59: R41         Business, Basis of Presentation and Summary of      HTML    758K 
                Significant Accounting Policies (Policies)                       
60: R42         Organization, Consolidation and Presentation of     HTML    667K 
                Financial Statements (Tables)                                    
61: R43         Segment Information (Tables)                        HTML    437K 
62: R44         Future Policy Benefits (Tables)                     HTML   1.71M 
63: R45         Policyholder Account Balances (Tables)              HTML   1.17M 
64: R46         Market Risk Benefits (Tables)                       HTML    777K 
65: R47         Separate Account (Tables)                           HTML    347K 
66: R48         Deferred Policy Acquisition Costs, Value of         HTML    976K 
                Business Acquired and Other Policy-Related                       
                Intangibles (Tables)                                             
67: R49         Reinsurance (Tables)                                HTML    169K 
68: R50         Closed Block (Tables)                               HTML    139K 
69: R51         Investments (Tables)                                HTML    809K 
70: R52         Derivatives (Tables)                                HTML    632K 
71: R53         Fair Value (Tables)                                 HTML    604K 
72: R54         Leases Leases (Tables)                              HTML    103K 
73: R55         Goodwill (Tables)                                   HTML    155K 
74: R56         Long-term and Short-term Debt (Tables)              HTML    130K 
75: R57         Collateral Financing Arrangements Collateral        HTML     80K 
                Financing Arrangements (Tables)                                  
76: R58         Junior Subordinated Debt Securities (Tables)        HTML    108K 
77: R59         Equity (Tables)                                     HTML    433K 
78: R60         Other Revenues and Other Expenses (Tables)          HTML    112K 
79: R61         Employee Benefit Plans (Tables)                     HTML    675K 
80: R62         Income Tax (Tables)                                 HTML    179K 
81: R63         Earnings Per Common Share (Tables)                  HTML     94K 
82: R64         Contingencies, Commitments and Guarantees (Tables)  HTML     83K 
83: R65         Quarterly Results of Operations (Unaudited)         HTML    140K 
                (Tables)                                                         
84: R66         Business, Basis of Presentation and Summary of      HTML     87K 
                Significant Accounting Policies -Upper-Medium                    
                Grade Discount Rate (Details)                                    
85: R67         Business, Basis of Presentation and Summary of      HTML    115K 
                Significant Accounting Policies - Future Adoption                
                (Details)                                                        
86: R68         Business, Basis of Presentation and Summary of      HTML    177K 
                Significant Accounting Policies - Summary Matrix                 
                (Details)                                                        
87: R69         Business, Basis of Presentation and Summary of      HTML    199K 
                Significant Accounting Policies - Transition Table               
                - Balance Sheet (Details)                                        
88: R70         Business, Basis of Presentation and Summary of      HTML    227K 
                Significant Accounting Policies - Transition Table               
                - Income Statement (Details)                                     
89: R71         Business, Basis of Presentation and Summary of      HTML    220K 
                Significant Accounting Policies - Transition Table               
                - SOE (Details)                                                  
90: R72         Business, Basis of Presentation and Summary of      HTML    181K 
                Significant Accounting Policies - Transition Table               
                - SCF (Details)                                                  
91: R73         Business, Basis of Presentation and Summary of      HTML    172K 
                Significant Accounting Policies - Transition Table               
                - SOCI (Details)                                                 
92: R74         Business, Basis of Presentation and Summary of      HTML    157K 
                Significant Accounting Policies - Narrative                      
                (Details)                                                        
93: R75         Segment Information (Earnings) (Details)            HTML    335K 
94: R76         Segment Information (Total Assets) (Details)        HTML    112K 
95: R77         Segment Information (Product Table) (Details)       HTML     80K 
96: R78         Segment Information (Premiums, Fees and Other       HTML     78K 
                Revenues by US and Foreign Operations) (Details)                 
97: R79         Segment Information (Narrative) (Details)           HTML    141K 
98: R80         Pending Disposition of MetLife Malaysia (Details)   HTML     74K 
99: R81         Disposition of MetLife Seguros S.A. (Details)       HTML     87K 
100: R82         Disposition of MetLife Poland and Greece -          HTML     87K  
                Narrative (Details)                                              
101: R83         Disposition of Metropolitan Property and Casualty   HTML     99K  
                Insurance Company - Narrative (Details)                          
102: R84         Future Policy Benefits - Transition Tables          HTML    260K  
                (Details)                                                        
103: R85         Future Policy Benefits - FPB on Balance Sheet       HTML    103K  
                (Details)                                                        
104: R86         Future Policy Benefits - Disaggregate Rollforwards  HTML    252K  
                (Details)                                                        
105: R87         Future Policy Benefits - Narrative (Details)        HTML     73K  
106: R88         Future Policy Benefits - FPB - Additional           HTML    125K  
                Insurance Liabilities (Details)                                  
107: R89         Future Policy Benefits - FPB Income Statement       HTML    111K  
                (Details)                                                        
108: R90         Future Policy Benefits - Participating Business -   HTML     74K  
                Narrative (Details)                                              
109: R91         Future Policy Benefits (Liabilities for Unpaid      HTML    332K  
                Claims and Claims Expense - Development Tables)                  
                (Details)                                                        
110: R92         Future Policy Benefits (Short-Duration Contracts    HTML    116K  
                Historical Claims) (Details)                                     
111: R93         Future Policy Benefits (Liabilities for Unpaid      HTML     94K  
                Claims - Methodology) (Details)                                  
112: R94         Future Policy Benefits (Reconciliation of           HTML    115K  
                Disclosure to Liability) (Details)                               
113: R95         Future Policy Benefits (Rollforward of Unpaid       HTML    104K  
                Claims) (Details)                                                
114: R96         Policyholder Account Balances - Transition Table    HTML    173K  
                (Details)                                                        
115: R97         Policyholder Account Balances - Amounts on Balance  HTML    100K  
                Sheet (Details)                                                  
116: R98         Policyholder Account Balances - LDTI Rollforward    HTML    161K  
                (Details)                                                        
117: R99         Policyholder Account Balances - Range of            HTML    347K  
                Guaranteed Minimum Crediting Rate (Details)                      
118: R100        Policyholder Account Balances - Narrative           HTML     81K  
                (Details)                                                        
119: R101        Market Risk Benefits - Transition Adjustments       HTML    123K  
                (Details)                                                        
120: R102        Market Risk Benefits - Balance Sheet (Details)      HTML     90K  
121: R103        Market Risk Benefits - Rollforward (Details)        HTML    147K  
122: R104        Separate Account Liabilities Balance Sheet          HTML     91K  
                (Details)                                                        
123: R105        Separate Account Liabilities Rollforward (Details)  HTML    119K  
124: R106        Separate Account Assets Fair Value (Details)        HTML    326K  
125: R107        Separate Accounts - Narrative (Details)             HTML     82K  
126: R108        Deferred Policy Acquisition Costs, Value of         HTML    179K  
                Business Acquired and Other Policy-Related                       
                Intangibles - Transition Table (Details)                         
127: R109        Deferred Policy Acquisition Costs, Value of         HTML    188K  
                Business Acquired and Other Policy-Related                       
                Intangibles (DAC and VOBA) (Details)                             
128: R110        Deferred Policy Acquisition Costs, Value of         HTML     88K  
                Business Acquired and Other Policy-Related                       
                Intangibles (DAC and VOBA by Segment) (Details)                  
129: R111        Deferred Policy Acquisition Costs, Value of         HTML     81K  
                Business Acquired and Other Policy-Related                       
                Intangibles (VODA and VOCRA) (Details)                           
130: R112        Deferred Policy Acquisition Costs, Value of         HTML     78K  
                Business Acquired and Other Policy-Related                       
                Intangibles (Negative VOBA) (Details)                            
131: R113        Deferred Policy Acquisition Costs, Value of         HTML    107K  
                Business Acquired and Other Policy-Related                       
                Intangibles (Estimated Future Amortization)                      
                (Details)                                                        
132: R114        Deferred Policy Acquisition Costs, Value of         HTML     97K  
                Business Acquired and Other Policy-Related                       
                Intangibles - Unearned Revenue (Details)                         
133: R115        Reinsurance (Effects of Reinsurance on Earnings)    HTML    128K  
                (Details)                                                        
134: R116        Reinsurance (Effects of Reinsurance on Balance      HTML    115K  
                Sheet) (Details)                                                 
135: R117        Reinsurance (Narrative) (Details)                   HTML    115K  
136: R118        Closed Block (Liabilities and Assets) (Details)     HTML    128K  
137: R119        Closed Block (Policyholder Dividend Obligation)     HTML     75K  
                (Details)                                                        
138: R120        Closed Block (Revenues and Expenses) (Details)      HTML     97K  
139: R121        Investments (Fixed Maturity Securities              HTML    117K  
                Available-For-Sale by Sector) (Details)                          
140: R122        Investments (Maturities of Fixed Maturity           HTML    101K  
                Securities) (Details)                                            
141: R123        Investments (Continuous Gross Unrealized Losses     HTML    124K  
                for Fixed Maturity Securities Available-For-Sale)                
                (Details)                                                        
142: R124        Investments (ACL for Fixed Maturity Securities AFS  HTML    112K  
                by Sector) (Details)                                             
143: R125        Investments (Equity Securities) (Details)           HTML     84K  
144: R126        Investments (Contractholder-Directed Equity         HTML     83K  
                Securities and FVO Securities) (Details)                         
145: R127        Investments (Mortgage Loans by Portfolio Segment)   HTML    117K  
                (Details)                                                        
146: R128        Investments (Mortgage Loans Allowance for Credit    HTML     94K  
                Loss Rollforward by Portfolio Segment) (Details)                 
147: R129        Investments (Modifications to Borrowers             HTML     81K  
                Experiencing Financial Difficulty) (Details)                     
148: R130        Investments (Credit Quality of Commercial Mortgage  HTML    133K  
                Loans) (Details)                                                 
149: R131        Investments (Credit Quality of Agricultural and     HTML    137K  
                Residential Mortgage Loans) (Details)                            
150: R132        Investments (Past Due and Interest Accrual Status   HTML     93K  
                of Mortgage Loans) (Details)                                     
151: R133        Investments (Real Estate and Real Estate Joint      HTML     95K  
                Ventures) (Details)                                              
152: R134        Investments (Leased Real Estate Investments -       HTML     94K  
                Operating Leases) (Details)                                      
153: R135        Investments (Concentrations of Credit Risk)         HTML     78K  
                (Details)                                                        
154: R136        Investments (Securities Lending and Repurchase      HTML     86K  
                Agreements) (Details)                                            
155: R137        Investments (Securities Lending and Repurchase      HTML    109K  
                Agreements Remaining Tenor ) (Details)                           
156: R138        Investments (Invested Assets on Deposit, Held In    HTML     80K  
                Trust and Pledged as Collateral) (Details)                       
157: R139        Investments (Consolidated Variable Interest         HTML     96K  
                Entities) (Details)                                              
158: R140        Investments (Unconsolidated Variable Interest       HTML     95K  
                Entities) (Details)                                              
159: R141        Investments (Net Investment Income) (Details)       HTML    105K  
160: R142        Investments (Supplemental Net Investment Income)    HTML     91K  
                (Details)                                                        
161: R143        Investments (Components of Net Investment Gains     HTML     97K  
                Losses - Asset Type) (Details)                                   
162: R144        Investments (Components of Net Investment Gains     HTML    100K  
                Losses - Transaction Type) (Details)                             
163: R145        Investments (Supplemental Net Investment Gains      HTML     88K  
                (Losses)) (Details)                                              
164: R146        Investments (Fixed Maturity Securities AFS - Sales  HTML    101K  
                and Disposals and Credit Loss) (Details)                         
165: R147        Investments (Evaluation of Fixed Maturity           HTML     86K  
                Securities AFS in an Unrealized Loss Position -                  
                Narrative) (Details)                                             
166: R148        Investments (Mortgage Loans - Narrative) (Details)  HTML    106K  
167: R149        Investments (Real Estate and Real Estate Joint      HTML     76K  
                Ventures - Narrative) (Details)                                  
168: R150        Investments (Operating Leases - Narrative)          HTML     84K  
                (Details)                                                        
169: R151        Investments (Other Invested Assets - Narrative)     HTML     73K  
                (Details)                                                        
170: R152        Investments (Cash Equivalents - Narrative)          HTML     72K  
                (Details)                                                        
171: R153        Investments (Invested Assets on Deposit, Held in    HTML     71K  
                Trust and Pledged as Collateral - Narrative)                     
                (Details)                                                        
172: R154        Investments (Collectively Significant Equity        HTML    113K  
                Method Investments - Narrative) (Details)                        
173: R155        Derivatives (Primary Risks) (Details)               HTML    178K  
174: R156        Derivatives Derivatives (Effects on the             HTML    187K  
                Consolidated Statement of Operations and                         
                Comprehensive Income (Loss)) (Details)                           
175: R157        Derivatives (Fair Value Hedges) (Details)           HTML     86K  
176: R158        Derivatives (Cash Flow Hedges) (Details)            HTML     76K  
177: R159        Derivatives (Hedges of Net Investments in Foreign   HTML     74K  
                Operations) (Details)                                            
178: R160        Derivatives (Credit Derivatives) (Details)          HTML    106K  
179: R161        Derivatives (Estimated Fair Value of Derivative     HTML    123K  
                Assets and Liabilities after Master Netting                      
                Agreements and Cash Collateral) (Details)                        
180: R162        Derivatives (Credit Risk on Freestanding            HTML     93K  
                Derivatives) (Details)                                           
181: R163        Derivatives (Embedded Derivatives) (Details)        HTML     78K  
182: R164        Derivatives (Narrative) (Details)                   HTML    135K  
183: R165        Fair Value (Recurring Fair Value Measurements)      HTML    239K  
                (Details)                                                        
184: R166        Fair Value (Quantitative Information) (Details)     HTML    172K  
185: R167        Fair Value (Unobservable Input Reconciliation)      HTML    208K  
                (Details)                                                        
186: R168        Fair Value (Nonrecurring Fair Value Measurements)   HTML     88K  
                (Details)                                                        
187: R169        Fair Value (Financial Instruments Carried at Other  HTML    122K  
                Than Fair Value) (Details)                                       
188: R170        Leases Lease Costs (Details)                        HTML     78K  
189: R171        Leases Leases (Details)                             HTML    108K  
190: R172        Leases Leases - (Narrative) (Details)               HTML     81K  
191: R173        Goodwill (Details)                                  HTML    120K  
192: R174        Long-term and Short-term Debt (Long-term and        HTML    132K  
                Short-term Outstanding) (Details)                                
193: R175        Long-term and Short-term Debt (Short-term with      HTML     81K  
                Maturities of Year or Less) (Details)                            
194: R176        Long-term and Short-term Debt (Credit Facilities)   HTML     90K  
                (Details)                                                        
195: R177        Long-term and Short-term Debt (Committed            HTML     99K  
                Facilities) (Details)                                            
196: R178        Long-term and Short-term Debt (Narrative)           HTML    169K  
                (Details)                                                        
197: R179        Long-term and Short-term Debt Long-term and         HTML     96K  
                Short-term Debt (Narrative - Line of Credit)                     
                (Details)                                                        
198: R180        Collateral Financing Arrangements Collateral        HTML     97K  
                Financing Arrangements (Associated with Closed                   
                Block) (Details)                                                 
199: R181        Collateral Financing Arrangements (Narrative)       HTML    106K  
                (Details)                                                        
200: R182        Junior Subordinated Debt Securities (Junior         HTML    108K  
                Subordinated Debt Securities) (Details)                          
201: R183        Junior Subordinated Debt Securities (Narrative)     HTML    106K  
                (Details)                                                        
202: R184        Equity - Preferred Stock (Details)                  HTML    116K  
203: R185        Equity - Preferred Stock Narrative (Details)        HTML    178K  
204: R186        Equity - Common Stock (Details)                     HTML     75K  
205: R187        Equity - Common Stock Narrative (Details)           HTML    106K  
206: R188        Equity - Stock-Based Compensation Plans Narrative   HTML    116K  
                (Details)                                                        
207: R189        Equity - Compensation Expense Related to            HTML     89K  
                Stock-Based Compensation for Phantom Stock-Based                 
                Awards (Details)                                                 
208: R190        Equity - Unrecognized Compensation Expense Related  HTML     88K  
                to Stock-Based Compensation (Details)                            
209: R191        Equity - Summary of Activity Related to Stock       HTML    129K  
                Options (Details)                                                
210: R192        Equity - Weighted Average Assumptions Used to       HTML    102K  
                Determine Fair Value of Stock Options (Details)                  
211: R193        Equity - Summary of Stock Option Exercise Activity  HTML     76K  
                (Details)                                                        
212: R194        Equity - Performance Share and Restricted Stock     HTML    106K  
                Unit (Details)                                                   
213: R195        Equity - Liability Award Activity (Details)         HTML    106K  
214: R196        Equity - Statutory Equity & Income Narrative        HTML     96K  
                (Details)                                                        
215: R197        Equity - Statutory Net Income (Loss) and Capital &  HTML     84K  
                Surplus (Details)                                                
216: R198        Equity - Dividend Restrictions (Details)            HTML     84K  
217: R199        Equity - Components of Accumulated Other            HTML    179K  
                Comprehensive Income (Loss) (Details)                            
218: R200        Equity - Reclassifications Out of Accumulated       HTML    149K  
                Other Comprehensive Income (Loss) (Details)                      
219: R201        Other Revenues and Other Expenses Other Revenues    HTML     96K  
                (Details)                                                        
220: R202        Other Revenues and Other Expenses Other Revenues    HTML     72K  
                (Narrative) (Details)                                            
221: R203        Other Expenses (Other Expenses) (Details)           HTML     95K  
222: R204        Employee Benefit Plans Employee Benefit Plans       HTML     97K  
                (Obligations, Funded Status, and Periodic Benefit                
                Costs) (Details)                                                 
223: R205        Employee Benefit Plans (Obligations and Funded      HTML    165K  
                Status) (Details)                                                
224: R206        Employee Benefit Plans (Paid Benefit Obligations    HTML     91K  
                and Accumulated Benefit Obligations in Excess of                 
                Fair Value) (Details)                                            
225: R207        Employee Benefit Plans (Net Periodic Benefit Costs  HTML    128K  
                and Other Changes Recognized in OCI) (Details)                   
226: R208        Employee Benefit Plans (Assumptions in Determining  HTML     85K  
                Benefit Obligations) (Details)                                   
227: R209        Employee Benefit Plans (Assumptions in Determining  HTML     89K  
                Net Periodic Benefit Costs) (Details)                            
228: R210        Employee Benefit Plans (Assumed Healthcare Cost     HTML     81K  
                Trend Rates) (Details)                                           
229: R211        Employee Benefit Plans (Actual & Target Allocation  HTML     90K  
                of Fair Value by Asset Class) (Details)                          
230: R212        Employee Benefit Plans (Estimated Fair Value on a   HTML    206K  
                Recurring Basis) (Details)                                       
231: R213        Employee Benefit Plans (Significant Unobservable    HTML    134K  
                Inputs) (Details)                                                
232: R214        Employee Benefit Plans (Expected Gross Benefit      HTML     87K  
                Payments) (Details)                                              
233: R215        Employee Benefit Plans (Narrative) (Details)        HTML     98K  
234: R216        Income Tax (Provision for Income Tax from           HTML     99K  
                Continuing Operations) (Details)                                 
235: R217        Income Tax (Income Loss from Continuing Operations  HTML     80K  
                Before Income Tax Expense from Domestic and                      
                Foreign Operations) (Details)                                    
236: R218        Income Tax (Reconciliation of Income Tax Provision  HTML    126K  
                between US Statutory Rate and As Reported for                    
                Continuing Operations) (Details)                                 
237: R219        Income Tax (Net Deferred Income Tax Assets and      HTML    121K  
                Liabilities) (Details)                                           
238: R220        Income Tax (Reconciliation of Unrecognized Tax      HTML     86K  
                Benefits) (Details)                                              
239: R221        Income Tax (Interest Accrued Related to             HTML     78K  
                Unrecognized Tax Benefits) (Details)                             
240: R222        Income Tax (Narrative) (Details)                    HTML     87K  
241: R223        Earnings Per Common Share (Earnings Per Common      HTML    122K  
                Share) (Details)                                                 
242: R224        Contingencies, Commitments and Guarantees           HTML     82K  
                (Asbestos Claims) (Details)                                      
243: R225        Contingencies, Commitments and Guarantees           HTML     75K  
                (Contingencies - Narrative) (Details)                            
244: R226        Contingencies, Commitments and Guarantees           HTML     87K  
                (Commitments and Guarantees - Narrative) (Details)               
245: R227        Quarterly Results of Operations (Unaudited)         HTML    141K  
                (Details)                                                        
246: R228        Consolidated Summary of Investments - Other Than    HTML    135K  
                Investments in Related Parties (Details)                         
247: R229        Condensed Financial Information (Parent Company)    HTML    189K  
                (Condensed Balance Sheet) (Details)                              
248: R230        Condensed Financial Information (Parent Company)    HTML     94K  
                (Condensed Balance Sheet - Insets) (Details)                     
249: R231        Condensed Financial Information (Parent Company)    HTML    156K  
                (Condensed Statements of Operations) (Details)                   
250: R232        Condensed Financial Information (Parent Company)    HTML    212K  
                (Condensed Statements of Cash Flows) (Details)                   
251: R233        Condensed Financial Information (Parent Company)    HTML     75K  
                (Investment in Subsidiaries - Narrative) (Details)               
252: R234        Condensed Financial Information (Parent Company)    HTML     89K  
                (Loans to Subsidiaries - Narrative) (Details)                    
253: R235        Condensed Financial Information (Parent Company)    HTML    146K  
                (Long-term Debt Outstanding) (Details)                           
254: R236        Condensed Financial Information (Parent Company)    HTML     83K  
                (Interest Expense) (Details)                                     
255: R237        Condensed Financial Information (Parent Company)    HTML    103K  
                (Long-term Debt - Narrative) (Details)                           
256: R238        Condensed Financial Information (Parent Company)    HTML     96K  
                (Support Agreements - Narrative) (Details)                       
257: R239        Consolidated Supplementary Insurance Information    HTML    127K  
                (Balance Sheet Items) (Details)                                  
258: R240        Consolidated Supplementary Insurance Information    HTML    119K  
                (Income Statement Items) (Details)                               
259: R241        Consolidated Reinsurance (Consolidated              HTML    110K  
                Reinsurance) (Details)                                           
260: R9999       Uncategorized Items - met-20231231.htm              HTML     93K  
262: XML         IDEA XML File -- Filing Summary                      XML    534K  
265: XML         XBRL Instance -- met-20231231_htm                    XML  27.72M  
261: EXCEL       IDEA Workbook of Financial Report Info              XLSX    937K  
15: EX-101.CAL  XBRL Calculations -- met-20231231_cal                XML    438K 
16: EX-101.DEF  XBRL Definitions -- met-20231231_def                 XML   4.32M 
17: EX-101.LAB  XBRL Labels -- met-20231231_lab                      XML   6.88M 
18: EX-101.PRE  XBRL Presentations -- met-20231231_pre               XML   5.46M 
14: EX-101.SCH  XBRL Schema -- met-20231231                          XSD    669K 
263: JSON        XBRL Instance as JSON Data -- MetaLinks            1,577±  2.58M  
264: ZIP         XBRL Zipped Folder -- 0001099219-24-000035-xbrl      Zip   2.38M  


‘EX-10.24 9’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 10.24.9
AMENDMENT NUMBER 8 TO THE
METLIFE AUXILIARY MATCH PLAN
(Amended and Restated, Effective January 1, 2008)


The MetLife Auxiliary Match Plan (the “Plan”) is hereby amended, effective as of December 1, 2023, as follows:

Section 4.15 shall be added with the following language:

4.15    Dodd-Frank Recoupment/Clawback: Notwithstanding anything contained herein to the contrary, a Participant’s Plan benefit shall be and remain subject to any incentive compensation clawback or recoupment policy currently in effect or as may be adopted by MetLife, Inc. or any of its Affiliates and, in each case, as may be amended from time to time. No such policy adoption or amendment shall in any event require the prior consent from a Participant. No recovery of compensation under such a clawback or recoupment policy will be an event giving rise to a right to resign for “good reason” or “constructive termination” (or similar term) under any agreement with MetLife, Inc. or any of its Affiliates.

IN WITNESS WHEREOF, the Company has caused this Amendment to be executed in its name and behalf this _20th___ day of __November______, 2023, by its officer thereunto duly authorized.
Metropolitan Life Insurance Company

By: ___/s/ Andrew J. Bernstein_____________________________
Andrew J. Bernstein, Plan Administrator

ATTEST: ___/s/ Danielle Hodorowski___________________________________




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/16/24IRANNOTICE
Filed on:2/15/248-K,  IRANNOTICE,  SC 13D/A
For Period end:12/31/2313F-HR
12/1/23
1/1/08
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/08/24  Nia Impact Advisors, LLC          PX14A6G     5/08/24    1:28K  MetLife, Inc.                     Securex Filings/FA
 3/04/24  MetLife, Inc.                     424B2                  2:980K                                   Donnelley … Solutions/FA
 2/26/24  MetLife, Inc.                     424B2                  1:742K                                   Donnelley … Solutions/FA


44 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/05/23  MetLife, Inc.                     8-K:5,9    10/03/23   13:1.1M                                   Donnelley … Solutions/FA
 5/09/23  MetLife, Inc.                     8-K:1,2,9   5/08/23   12:1M                                     Donnelley … Solutions/FA
 2/23/23  MetLife, Inc.                     10-K       12/31/22  244:62M
 2/18/22  MetLife, Inc.                     10-K       12/31/21  253:63M
 6/29/21  MetLife, Inc.                     8-K:5,9     6/29/21   12:247K
 2/19/21  MetLife, Inc.                     10-K       12/31/20  245:65M
 9/10/20  MetLife, Inc.                     8-K:3,5,8,9 9/08/20   15:660K                                   Donnelley … Solutions/FA
 2/21/20  MetLife, Inc.                     10-K       12/31/19  254:83M
 1/15/20  MetLife, Inc.                     8-K:8,9     1/15/20   13:431K                                   Donnelley … Solutions/FA
 1/09/20  MetLife, Inc.                     8-K:3,5,8,9 1/07/20   14:663K                                   Donnelley … Solutions/FA
 3/05/19  MetLife, Inc.                     8-K:5,8,9   2/27/19    4:266K
 2/22/19  MetLife, Inc.                     10-K       12/31/18  261:80M
12/13/18  MetLife, Inc.                     8-K:5,9    12/11/18    3:103K                                   Donnelley … Solutions/FA
11/08/18  MetLife, Inc.                     10-Q        9/30/18  143:44M                                    Metropolitan Life Ins Co
 6/04/18  MetLife, Inc.                     8-K:3,5,8,9 5/30/18    7:673K                                   Donnelley … Solutions/FA
 5/08/18  MetLife, Inc.                     10-Q        3/31/18  138:34M                                    Metropolitan Life Ins Co
 5/07/18  MetLife, Inc.                     8-K:5,9     5/01/18    3:63K                                    Donnelley … Solutions/FA
 3/22/18  MetLife, Inc.                     8-K:3,5,8,9 3/20/18    5:363K                                   Donnelley … Solutions/FA
 2/20/18  MetLife, Inc.                     8-K:5,9     2/15/18    8:161K                                   Donnelley … Solutions/FA
11/06/17  MetLife, Inc.                     10-Q        9/30/17  144:43M                                    Metropolitan Life Ins Co
10/24/17  MetLife, Inc.                     8-K:3,5,9  10/19/17    2:30K                                    Donnelley … Solutions/FA
 8/07/17  MetLife, Inc.                     8-K:1,9     8/04/17    3:577K                                   Donnelley … Solutions/FA
 3/01/17  MetLife, Inc.                     10-K       12/31/16  271:82M                                    Metropolitan Life Ins Co
11/18/16  MetLife, Inc.                     S-8        11/18/16    4:109K                                   Donnelley … Solutions/FA
 8/05/16  MetLife, Inc.                     10-Q        6/30/16  120:41M                                    Metropolitan Life Ins Co
 5/06/16  MetLife, Inc.                     10-Q        3/31/16  121:33M                                    Metropolitan Life Ins Co
 2/25/16  MetLife, Inc.                     10-K       12/31/15  266:74M                                    Metropolitan Life Ins Co
11/05/15  MetLife, Inc.                     10-Q        9/30/15  127:50M                                    Metropolitan Life Ins Co
 8/06/15  MetLife, Inc.                     10-Q        6/30/15  123:49M                                    Metropolitan Life Ins Co
 4/30/15  MetLife, Inc.                     8-K:5,9     4/28/15    3:217K                                   Donnelley … Solutions/FA
 2/27/15  MetLife, Inc.                     10-K12/31/14  265:116M                                   Metropolitan Life Ins Co
12/11/14  MetLife, Inc.                     8-K:5,9    12/09/14   12:532K                                   Donnelley … Solutions/FA
 8/14/14  MetLife, Inc.                     S-8         8/14/14    4:190K                                   Donnelley … Solutions/FA
 8/14/14  MetLife, Inc.                     S-8         8/14/14    4:125K                                   Donnelley … Solutions/FA
 2/27/14  MetLife, Inc.                     10-K       12/31/13  258:110M                                   Metropolitan Life Ins Co
11/07/13  MetLife, Inc.                     10-Q        9/30/13  130:71M                                    Brighthouse Fd UL f… Ins
 2/27/13  MetLife, Inc.                     10-K12/31/12  276:68M                                    Donnelley … Solutions/FA
 2/15/13  MetLife, Inc.                     8-K:5,8,9   2/11/13   16:795K                                   Donnelley … Solutions/FA
11/07/12  MetLife, Inc.                     10-Q        9/30/12  173:50M                                    Donnelley … Solutions/FA
 5/04/12  MetLife, Inc.                     8-K:5,9     5/01/12    2:31K                                    Donnelley … Solutions/FA
 6/10/05  MetLife, Inc.                     8-A12B                 3:61K                                    Donnelley … Solutions/FA
 3/29/00  MetLife, Inc.                     S-1/A                 16:1.9M                                   Donnelley … Solutions/FA
 3/09/00  MetLife, Inc.                     S-1/A                 36:2.2M                                   Donnelley … Solutions/FA
11/23/99  MetLife, Inc.                     S-1                   13:3.6M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001099219-24-000035   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 6:45:52.4am ET